165. More Doubts about Crestor (Rosavustatin)!

A recent article in the BMJ highlighted concerns about the statin Crestor which in 2014 was the most prescribed brand name drug in the US, with 22.3 million prescriptions at a cost of $5.8bn. World-wide sales for 2013 were $8.2bn (1). The report is by Sidney Wolfe, who founded Public Citizen based in Washington DC […]

165. More Doubts about Crestor (Rosavustatin)! Read More ยป